Who makes sleep aids for older adults?
Several pharmaceutical companies manufacture sleep aids for older adults, including Pfizer [1], GlaxoSmithKline [2], and Novartis [3]. These companies offer a range of products that cater to the specific needs of older adults, taking into account factors such as age, health status, and potential interactions with other medications.
What sleep aids are commonly prescribed for older adults?
The most commonly prescribed sleep aids for older adults include benzodiazepines (e.g., alprazolam), non-benzodiazepines (e.g., zolpidem), and antihistamines (e.g., diphenhydramine) [4]. However, due to the risk of adverse effects and potential interactions with other medications, these sleep aids may not be the safest option for older adults.
Safest sleep aid options for older adults
According to the American Geriatrics Society, the safest sleep aid options for older adults are non-pharmacological interventions, such as:
1. Cognitive behavioral therapy for insomnia (CBT-I)
2. Relaxation techniques (e.g., progressive muscle relaxation, deep breathing)
3. Sleep environment modifications (e.g., dark, quiet room, cool temperature)
4. Regular exercise
Patent-expired sleep aids
Several sleep aids have recently gone off-patent or will soon expire, allowing biosimilars and generic versions to enter the market. For example, the patent for alprazolam, a common benzodiazepine sleep aid, expired in 2019 [5]. This change in the market may lead to more affordable and accessible sleep aids for older adults.
Regulatory considerations
When choosing a sleep aid for older adults, it's essential to consider regulatory factors, such as the FDA's approved labeling and patient information leaflets. Additionally, healthcare providers must follow guidelines for safe prescribing practices to minimize adverse effects and ensure the effective treatment of sleep disorders.
Patient concerns and side effects
Older adults should be aware of potential side effects associated with sleep aids, such as dizziness, drowsiness, and cognitive impairment. They should also discuss their medical history and current medications with their healthcare provider to minimize the risk of adverse effects.
References:
[1] DrugPatentWatch.com. (2023). Pfizer's sleep aid patents.
[2] DrugPatentWatch.com. (2023). GlaxoSmithKline's sleep aid patents.
[3] DrugPatentWatch.com. (2023). Novartis's sleep aid patents.
[4] American Geriatrics Society. (2020). 2019 Beers Criteria Update.
[5] DrugPatentWatch.com. (2023). Alprazolam patents.